Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans

Neuroscience

Volumn 73, Issue 1, 1996, Pages 259-265

  Aley, K O ^a   Reichling, D B ^a   Levine, J D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anti neoplastic; axonal transport; cancer; chemotherapy; painful peripheral neuropathy; vinca alkaloids

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; VINCRISTINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN CELL; HYPERALGESIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROPATHY; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SIDE EFFECT;

EID: 0029938439     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00020-6     Document Type: Article

References (47)

1. Ashburn M. A. and Lipman A. G. (1993) Management of pain in the cancer patient. Anesth. Analg. 76, 402-416.
2. Beijnen J. H., Vendrig D. E. M. M. and Underberg W. J. M. (1988) Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids. J. Parent. Sci. Tech. 43, 84-87.
3. Braund K. G., McGuire J. A. and Amling K. A. (1987) Peripheral neuropathy associated with malignant neoplasms in dogs. Vet. Path. 24, 16-21.
4. Campbell J. N., Raja S. N., Meyer R. A. and Mackinnon S. E. (1988) Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 32, 89-94.
5. Casey E. B., Jellife A. M., Le Quesne P. M. and Millett Y. L. (1973) Vincristine neuropathy. Brain 96, 69-86.
6. Davis K. D., Meyer R. A. and Campbell J. N. (1993) Chemosensitivity and sensitization of nociceptive afferents that innervate the hairy skin of monkey. J. Neurophysiol. 69, 1071-1081.
7. Dunham N. W. and Miya T. S. (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. pharmac. Ass. 46, 208-209.
8. Favaro G., Di Gregorio F., Panozzo C. and Fiori M. G. (1988) Ganglioside treatment of vincristine-induced neuropathy. An electrophysiologic study. Toxicology 49, 325-329.
9. Forman A. (1990) Peripheral neuropathy in cancer patients: clinical types, etiology, and presentation. Oncology (Huntington) 4, 85-89.
10. Forman A. (1990) Peripheral neuropathy in cancer patients: incidence, features, and pathophysiology. Oncology (Huntington) 4, 57-62.
11. Golden D. L. and Langston V. C. (1988) Uses of vincristine and vinblastine in dogs and cats. J. Am. vet. Med. Ass. 193, 1114-1118.
12. Green L. S., Donoso J. A., Heller B. I. and Samson F. E. (1977) Axonal transport disturbances in vincristine-induced peripheral neuropathy. Ann. Neurol 1, 255-262.
13. Gubisch N. J., Norena D. and Perlia C. P. (1963) Experience with vincristine in solid tumors. Cancer Chemother. Rep. 32.
14. Hargreaves K., Dubner R., Brown F., Flores C. and Joris J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-88.
15. Hayakawa K., Sobue G., Itoh T. and Mitsuma T. (1994) Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol, on adult rat sympathetic ganglion explants in vitro. Life Sci. 55, 519-525.
16. Holland J. F., Scharlau C., Gailani S., Krant M. J., Olson K. B., Horton J., Shnider B. I., Lynch J. J., Owens A. and Carbone P. P. (1973) Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res. 33, 1258-1264.
17. Jackson D. V., Wells H. B. and Atkins J. N. (1988) Amelioration of vincristine neurotoxicity by glutamic acid. Am. J. Med. 84, 1016-1022.
18. Kaplan R. S. and Wiernik P. H. (1982) Neurotoxicity of antineoplastic drugs. Semin. Oncol. 9, 103-130.
19. Kim S. H. and Chung J. M. (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355-363.
20. Kinnman E. and Levine J. D. (1995) Sensory and sympathetic contributions to nerve injury-induced abnormalities in the rat. Neuroscience 64, 751-789.
21. Knyihar-Csillik E., Szucs A. and Csillik B. (1982) Iontophoretically applied microtubule inhibitors induce transganglionic degenerative atrophy of primary central nociceptive terminals and abolish chronic autochtonous pain. Acta neurol. scand. 66, 401-412.
22. Konings P. N., Makkink W. K., van Delft A. M. and Ruigt G. S. (1994) Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro. Brain Res. 640, 195-204.
23. LaMotte R. H., Thalhammer J. G. and Robinson C. J. (1982) Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heat. J. Neurosci. 2, 756-781.
24. Leem J. W., Willis W. D. and Chung J. M. (1993) Cutaneous sensory receptors in the rat foot. J. Neurophysiol. 69, 1684-1699.
25. Le Quesne P. M., Fowler C. J. and Hardington A. E. (1985) A study of the effects of isaxonine on vincristine-induced peripheral neuropathy in man and regeneration following peripheral nerve crush in the rat. J. Neurol. Neurosurg. Psychiat. 48, 933-935.
26. Levine J. D. and Taiwo Y. O. (1989) Involvement of the mu-opiate receptor in peripheral analgesia. Neuroscience 32, 571-575.
27. Lewin G. R., Ritter A. M. and Mendell L. M. (1993) Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J. Neurosci. 13, 2136-2148.
28. Lewis M. E., Neff N. T., Contreras P. C., Stong D. B., Oppenheim R. W., Grebow P. E. and Vaught J. L. (1993) Insulin-like growth factor-I: potential for treatment of motor neuronal disorders. Expl Neurol. 124, 73-88.
29. Lewis T. (1935) Experiments relating to cutaneous hyperalgesia and its spread through somatic nerves. Clin. Sci. 2, 373-423.
30. Lindblom W. and Verillo R. T. (1979) Sensory functions in chronic neuralgia. J. Neurol. Neurosurg. Psychiat. 42, 422-435.
31. Marsden J. H. (1972) Mechanism of Action of the Vinca Alkaloids, Vol. 2. Cancer Chemotherapy. Grune & Stratton, New York.
32. Meller S. T., Gebhart G. F. and Maves T. J. (1992) Neonatal capsaicin treatment prevents the development of the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Pain 5, 317-321.
33. Oakes S. G., Santone K. S. and Powis G. (1987) Effect of some anticancer drugs on the surface membrane electrical properties of differentiated murine neuroblastoma cells. J. natn. Cancer Inst. 79, 155-161.
34. Price D. D., Bennett G. J. and Rafii A. (1989) Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain 36, 273-288.
35. Sandler S. G., Tobin W. and Henderson E. S. (1969) Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology 19, 367-374.
36. Shir Y. and Seltzer Z. (1991) Effects of sympathectomy in a model of causalgiform pain produced by partial sciatic nerve injury in rats. Pain 45, 309-320.
37. Steen K. H., Reeh P. W., Anton F. and Handwerker H. O. (1992) Protons selectively induce lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin, in vitro. J. Neurosci. 12, 86-95.
38. Stein C., Millan M. J., Shippenberg T. S., Peters K. and Herz A. (1989) Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J. Pharmac. exp. Ther. 248, 1269-1275.
39. Taiwo Y. O., Coderre T. J. and Levine J. D. (1989) The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain Res. 487, 148-151.
40. Thomas P. K. (1975) Symptomatology and differential diagnosis of peripheral neuropathy. In Peripheral Neuropathy (eds Dyck P. J., Thomas P. K. and Lambert E. A.), Vol. 1, pp. 495-512. W. B. Saunders, Philadelphia.
41. Treede R. D., Davis K. D., Campbell J. N. and Raja S. N. (1992) The plasticity of cutaneous hyperalgesia during sympathetic ganglion blockade in patients with neuropathic pain. Brain 115, 607-621.
42. van Kooten B., van Dieman H. A., Groenhout K. M., Huijgens P. C., Ossenkopple G. J., Nauta J. J. and Heimans J. J. (1992) A pilot study of the influence of a corticotrophin (4-9) analogue on vinca-alkaloid induced neuropathy. Archs Neurol. 49, 1027-1031.
43. Vendrig D. E. M. M., Beijnen J. H., van der Houwen O. A. G. J. and Holthuis J. J. M. (1989) Degradation kinetics of vincristine sulphate and vindesine sulphate in aqueous solutions. Int. J. Pharmac. 50, 189-196.
44. Vuorinen V., Roytta M. and Raine C. S. (1989) The long-term effects of a single injection of taxol upon peripheral nerve axons. J. Neurocytol. 18, 775-783.
45. Wallin G., Torebjork E. and Hallin R. (1976) Preliminary observations on the pathophysiology of hyperalgesia in the causalgic pain syndrome. In Sensory Functions of the Skin in Primates: With Special Reference to Man (ed. Zotterman Y.), pp. 489-499. Pergamon Press, Oxford.
46. Watzman N., Barry I. H., Kinnard J. W. J. and Buckley J. P. (1967) Influence of certain parameters on the performance of mice on the rotarod. Archs int. Pharmacodyn. Ther. 169, 362-374.
47. Weiss H. D., Walker M. D. and Wernick D. H. (1974) Neurotoxicity of commonly used neoplastic agents. New Engl. J. Med. 29, 75-81 and 127-133.